Advanz exploited lack of rivals to hike drug's price, UK regulator tells judge
Advanz Pharma exploited its power over a thyroid medicine market lacking any competitive pressure by raising the price dramatically, the UK competition watchdog told a judge today in Advanz's ongoing appeal...To view the full article, register now.
Already a subscriber? Click here to view full article